Wangbin Zhou
Stock Analyst at Citi
(3.50)
# 2,086
Out of 4,396 analysts
20
Total ratings
29.4%
Success rate
17.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Wangbin Zhou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1672 Ascletis Pharma Inc. | Reiterated: Buy | $32.00 | $10.13 | +215.89% | 2 | Feb 3, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $105.00 → $110.00 | $73.80 | +49.05% | 2 | Aug 28, 2025 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Maintained: Buy | $560.00 | $402.60 | +39.10% | 1 | Aug 20, 2025 | |
| HKG: 0013 HUTCHMED (China) Limited | Maintained: Buy | $42.00 → $36.00 | $16.88 | +113.27% | 2 | Aug 11, 2025 | |
| HKG: 1530 3SBio Inc. | Maintained: Buy | $21.00 → $36.00 | $16.37 | +119.91% | 2 | Jul 28, 2025 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $98.00 → $185.00 | $86.00 | +115.12% | 3 | Jul 28, 2025 | |
| HKG: 1877 Shanghai Junshi Biosciences Co., Ltd. | Maintained: Buy | $32.00 | $15.99 | +100.13% | 1 | Jul 28, 2025 | |
| HKG: 6996 Antengene Corporation Limited | Downgraded: Hold | $3.50 | $3.36 | +4.17% | 1 | Jun 27, 2025 | |
| HKG: 9995 RemeGen Co., Ltd. | Maintained: Buy | $32.00 | $69.00 | n/a | 1 | Mar 31, 2025 | |
| LEGN Legend Biotech | Maintained: Buy | $95 | $33.49 | n/a | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25.00 → $40.00 | $27.24 | n/a | 2 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60.00 | $54.70 | n/a | 1 | Dec 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52.00 | $33.90 | n/a | 1 | Dec 5, 2024 |
Ascletis Pharma Inc.
Feb 3, 2026
Reiterated: Buy
Price Target: $32.00
Current: $10.13
Upside: +215.89%
Innovent Biologics, Inc.
Aug 28, 2025
Maintained: Buy
Price Target: $105.00 → $110.00
Current: $73.80
Upside: +49.05%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Aug 20, 2025
Maintained: Buy
Price Target: $560.00
Current: $402.60
Upside: +39.10%
HUTCHMED (China) Limited
Aug 11, 2025
Maintained: Buy
Price Target: $42.00 → $36.00
Current: $16.88
Upside: +113.27%
3SBio Inc.
Jul 28, 2025
Maintained: Buy
Price Target: $21.00 → $36.00
Current: $16.37
Upside: +119.91%
Akeso, Inc.
Jul 28, 2025
Maintained: Buy
Price Target: $98.00 → $185.00
Current: $86.00
Upside: +115.12%
Shanghai Junshi Biosciences Co., Ltd.
Jul 28, 2025
Maintained: Buy
Price Target: $32.00
Current: $15.99
Upside: +100.13%
Antengene Corporation Limited
Jun 27, 2025
Downgraded: Hold
Price Target: $3.50
Current: $3.36
Upside: +4.17%
RemeGen Co., Ltd.
Mar 31, 2025
Maintained: Buy
Price Target: $32.00
Current: $69.00
Upside: n/a
Legend Biotech
Mar 12, 2025
Maintained: Buy
Price Target: $95
Current: $33.49
Upside: n/a
Jan 15, 2025
Maintained: Hold
Price Target: $25.00 → $40.00
Current: $27.24
Upside: n/a
Dec 30, 2024
Maintained: Buy
Price Target: $60.00
Current: $54.70
Upside: n/a
Dec 5, 2024
Maintained: Buy
Price Target: $52.00
Current: $33.90
Upside: n/a